Stopping the stones

Science

Volumn 330, Issue 6002, 2010, Pages 325-326

  Coe, Fredric L ^a   Asplin, John R ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b LithoLink Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CITRIC ACID; CYSTEINE; GLYCOSAMINOGLYCAN; CYSTINE; DRUG DERIVATIVE; L CYSTINE DIMETHYLESTER; L-CYSTINE DIMETHYLESTER;

AMINO ACID; CALCIUM; CRYSTALLIZATION; DISEASE PREVALENCE; MORBIDITY; OXALATE; URINE;

CALCIUM STONE; CRYSTALLIZATION; CYSTINURIA; HUMAN; NEPHROLITHIASIS; PRIORITY JOURNAL; SHORT SURVEY; URINE PH; ANIMAL; CHEMISTRY; DRUG DESIGN; GENETICS; METABOLISM; MOUSE; NOTE; SOLUBILITY;

UNITED STATES;

ANIMALS; CRYSTALLIZATION; CYSTINE; CYSTINURIA; DRUG DESIGN; HUMANS; KIDNEY CALCULI; MICE; SOLUBILITY;

EID: 77957964708     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1197207     Document Type: Short Survey

References (13)

1. A. P. Evan et al., Kidney Int. 69, 2227 (2006).
2. J. D. Rimer et al., Science 330, 337 (2010).
3. J. Chillarón et al., Nat. Rev. Nephrol. 6, 424 (2010).
4. E. Pras et al., Nat. Genet. 6, 415 (1994).
5. L. Feliubadaló et al., International Cystinuria Consortium, Nat. Genet. 23, 52 (1999).
6. J. S. Rodman et al., Clin. Nephrol. 22, 273 (1984).
7. A. Lindell, T. Denneberg, E. Edholm, J. O. Jeppsson, Nephron 71, 407 (1995).
8. Y. Nakagawa, J. R. Asplin, D. S. Goldfarb, J. H. Parks, F. L. Coe, J. Urol. 164, 1481 (2000).
9. D. J. Dolin, J. R. Asplin, L. Flagel, M. Grasso, D. S. Goldfarb, J. Endourol. 19, 429 (2005).
10. C. Y. Pak, C. Fuller, K. Sakhaee, J. E. Zerwekh, B. V. Adams, J. Urol. 136, 1003 (1986).
11. M. Font-Llitjós et al., Am. J. Physiol. Renal Physiol. 293, F732 (2007).
12. M. J. Wilmer et al., Pediatr. Res. 62, 151 (2007).
13. J.R.A. is a partner in the Ravine group, a company that focuses on developing treatments for calcium kidney stones.